4-Chloroaniline

4-Chloroaniline

SCHEMBL2226595

CNS(=O)(=O)c1ccccc1.Nc1ccc(Cl)cc1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.67
CA1 P00915 1/20 0.67
CA2 P00918 1/20 0.67
CA3 P07451 1/20 0.67
CA4 P22748 1/20 0.67
CA6 P23280 1/20 0.67
CA5A P35218 1/20 0.67
CA7 P43166 1/20 0.67
CA9 Q16790 1/20 0.67
CA13 Q8N1Q1 1/20 0.67
CA14 Q9ULX7 1/20 0.67
CA5B Q9Y2D0 1/20 0.67
KEAP1 Q14145 1/20 0.54
KMT2A Q03164 5/20 0.52
MEN1 O00255 4/20 0.52
PRMT1 Q99873 1/20 0.51
LMNA P02545 2/20 0.48
NR3C2 P08235 1/20 0.47
TDP1 Q9NUW8 1/20 0.46
EGFR P00533 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL687206 0.81 SMN1; SMN2 (0.64) CA12CA1CA2CA3CA4
SCHEMBL31520571 0.81 SMN1; SMN2 (0.64) CA12CA1CA2CA3CA4
SCHEMBL2442745 0.81 CA1 (1.00) CA12CA1CA2CA3CA4
SCHEMBL18580 0.81 NR3C2 (0.64) CA12CA1CA2CA3CA4
Hydrochloric Acid SCHEMBL5344901 0.79 SMN1; SMN2 (0.61) CA12CA1CA2CA3CA4
SCHEMBL10617367 0.79 CA1 (0.95) CA12CA1CA2CA3CA4
SCHEMBL11512091 0.79 CA1 (0.95) CA12CA1CA2CA3CA4
SCHEMBL27420174 0.79 CA1 (0.59) CA12CA1CA2CA3CA4
Hydrochloric Acid SCHEMBL1807459 0.79 NR3C2 (0.62) CA12CA1CA2CA3CA4
SCHEMBL11514359 0.79 NR3C2 (0.62) CA12CA1CA2CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP disclosed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO disclosed